Javier Arbizu
YOU?
Author Swipe
View article: Peripheral immunity patterns, imaging features, and clinical outcomes in patients with gait impairment and ventriculomegaly on brain MRI
Peripheral immunity patterns, imaging features, and clinical outcomes in patients with gait impairment and ventriculomegaly on brain MRI Open
Introduction Ventricular enlargement is a common finding on brain MRI in patients with gait impairment, particularly in those with idiopathic normal pressure hydrocephalus (iNPH). However, iNPH shares several clinical and radiological feat…
View article: Atypical Frontotemporal Dementia Associated With <i>SQSTM1</i> Gene Mutation: A Clinicopathological Case
Atypical Frontotemporal Dementia Associated With <i>SQSTM1</i> Gene Mutation: A Clinicopathological Case Open
A 78‐year‐old man presented with a six‐year history of progressive memory decline, initially manifesting as recent memory impairment and mild anomia, which gradually evolved into motor clumsiness, gait disturbances, language difficulties, …
View article: Comment by European Alzheimer’s Disease Consortium (EADC) investigators on the negative recommendation of the CHMP on the marketing authorization of donanemab for early Alzheimer’ s disease
Comment by European Alzheimer’s Disease Consortium (EADC) investigators on the negative recommendation of the CHMP on the marketing authorization of donanemab for early Alzheimer’ s disease Open
View article: Bone SPECT/CT in the diagnosis and treatment decision making of axial pain
Bone SPECT/CT in the diagnosis and treatment decision making of axial pain Open
Purpose To explore the usefulness of bone SPECT/CT for providing additional information to Magnetic Resonance Imaging (MRI) in patients with axial pain, and for guiding the site of spinal injections. Methods We studied 194 patients with ax…
View article: Combination of amyloid and FDG PET for the prediction of short-term conversion from MCI to Alzheimer´s disease in the clinical practice
Combination of amyloid and FDG PET for the prediction of short-term conversion from MCI to Alzheimer´s disease in the clinical practice Open
View article: Clinical Research on Positron Emission Tomography Imaging of the Neuro-Stimulation System in Patients with Cochleo-Vestibular Implants: Is There a Response Beyond the Peripheral Organ?
Clinical Research on Positron Emission Tomography Imaging of the Neuro-Stimulation System in Patients with Cochleo-Vestibular Implants: Is There a Response Beyond the Peripheral Organ? Open
Introduction: In patients refractory to vestibular rehabilitation in the management of bilateral vestibulopathy, the cochleo-vestibular implant has emerged as a viable alternative to enhance both audiovestibular function and quality of lif…
View article: The basics of PET molecular imaging in neurodegenerative disorders with dementia and/or parkinsonism
The basics of PET molecular imaging in neurodegenerative disorders with dementia and/or parkinsonism Open
Positron emission tomography (PET) imaging biomarkers have become crucial in understanding and diagnosing neurodegenerative disorders. PET imaging allows for the in vivo quantification of molecular targets with high sensitivity, aiding in …
View article: Peripheral Immunity Patterns, Imaging Features, and Clinical Outcomes in Patients with Gait Impairment and Ventriculomegaly on Brain MRI
Peripheral Immunity Patterns, Imaging Features, and Clinical Outcomes in Patients with Gait Impairment and Ventriculomegaly on Brain MRI Open
View article: Updated appropriate use criteria for amyloid and tau PET: A report from the Alzheimer's Association and Society for Nuclear Medicine and Molecular Imaging Workgroup
Updated appropriate use criteria for amyloid and tau PET: A report from the Alzheimer's Association and Society for Nuclear Medicine and Molecular Imaging Workgroup Open
INTRODUCTION The Alzheimer's Association and the Society of Nuclear Medicine and Molecular Imaging convened a multidisciplinary workgroup to update appropriate use criteria (AUC) for amyloid positron emission tomography (PET) and to develo…
View article: 20541. CARACTERÍSTICAS CLÍNICAS Y PATRONES DE PET CEREBRAL CON 18F-FDG EN PACIENTES CON PARÁLISIS SUPRANUCLEAR PROGRESIVA CON Y SIN DILATACIÓN VENTRICULAR
20541. CARACTERÍSTICAS CLÍNICAS Y PATRONES DE PET CEREBRAL CON 18F-FDG EN PACIENTES CON PARÁLISIS SUPRANUCLEAR PROGRESIVA CON Y SIN DILATACIÓN VENTRICULAR Open
View article: 21106. PATRÓN DE HIPOMETABOLISMO LATE-LIKE EN UNA COHORTE DE PACIENTES CON DETERIORO COGNITIVO LEVE: CARACTERÍSTICAS CLÍNICAS, CARGA DE AMILOIDE Y CONVERSIÓN A DEMENCIA
21106. PATRÓN DE HIPOMETABOLISMO LATE-LIKE EN UNA COHORTE DE PACIENTES CON DETERIORO COGNITIVO LEVE: CARACTERÍSTICAS CLÍNICAS, CARGA DE AMILOIDE Y CONVERSIÓN A DEMENCIA Open
View article: 20331. FACTORES CLÍNICOS Y DE IMAGEN RELACIONADOS CON LA MORTALIDAD EN LA ENFERMEDAD DE PARKINSON
20331. FACTORES CLÍNICOS Y DE IMAGEN RELACIONADOS CON LA MORTALIDAD EN LA ENFERMEDAD DE PARKINSON Open
View article: 20277. GÉNERO Y ENFERMEDAD DE PARKINSON: DIFERENCIAS CLÍNICAS Y DE IMAGEN
20277. GÉNERO Y ENFERMEDAD DE PARKINSON: DIFERENCIAS CLÍNICAS Y DE IMAGEN Open
View article: Issue Information
Issue Information Open
View article: EANM practice guidelines for an appropriate use of PET and SPECT for patients with epilepsy
EANM practice guidelines for an appropriate use of PET and SPECT for patients with epilepsy Open
View article: Agrypnia Excitata and Supranuclear Vertical Gaze Palsy Linked to <scp>Anti‐Ma</scp> Encephalitis
Agrypnia Excitata and Supranuclear Vertical Gaze Palsy Linked to <span>Anti‐Ma</span> Encephalitis Open
Paraneoplastic neurological syndromes result from cancer's immune impact on the nervous system.1 Anti-Ma-associated encephalitis causes diencephalic, brainstem, and limbic symptoms such as memory loss, narcolepsy and rapid eye movement (RE…
View article: The impact of amyloid‐PET and FDG‐PET on the progression from amnestic MCI to AD dementia in clinical practice
The impact of amyloid‐PET and FDG‐PET on the progression from amnestic MCI to AD dementia in clinical practice Open
Background Alzheimer disease (AD) is the most common cause of dementia worldwide. It is known that cerebral amyloid aggregation and neurodegeneration are first steps in the physiopathology of AD. In the prodromal phase, a clinical diagnosi…
View article: Updated Appropriate Use Criteria for Amyloid and Tau PET
Updated Appropriate Use Criteria for Amyloid and Tau PET Open
Background The Alzheimer’s Association and Society for Nuclear Medicine and Molecular Imaging convened a Workgroup to update previous Appropriate Use Criteria (AUC) for amyloid PET (Johnson 2013) and develop the first AUC for tau PET. The …
View article: Efficacy of [177Lu]Lu-DOTATATE in metastatic neuroendocrine neoplasms of different locations: data from the SEPTRALU study
Efficacy of [177Lu]Lu-DOTATATE in metastatic neuroendocrine neoplasms of different locations: data from the SEPTRALU study Open
Background Peptide receptor radionuclide therapy (PRRT) is one of the most promising therapeutic strategies in neuroendocrine neoplasms (NENs). Nevertheless, its role in certain tumor sites remains unclear. This study sought to elucidate t…
View article: Sporadic Creutzfeldt–Jakob disease is associated with reorganization of metabolic connectivity in a pathological brain network
Sporadic Creutzfeldt–Jakob disease is associated with reorganization of metabolic connectivity in a pathological brain network Open
Background and purpose Although sporadic Creutzfeldt–Jakob disease (sCJD) is a rare cause of dementia, it is critical to understand its functional networks as the prion protein spread throughout the brain may share similar mechanisms with …
View article: Towards optimization of restriction protocol for Lu-DOTATE patients
Towards optimization of restriction protocol for Lu-DOTATE patients Open
View article: Finding our way through the labyrinth of dementia biomarkers
Finding our way through the labyrinth of dementia biomarkers Open
View article: Amyloid-PET and 18F-FDG-PET in the diagnostic investigation of Alzheimer's disease and other dementias
Amyloid-PET and 18F-FDG-PET in the diagnostic investigation of Alzheimer's disease and other dementias Open
View article: ROL DEL PSICÓLOGO EN LA POST·PANDEMIA: Una mirada desde la Psicología de la Emergencia.
ROL DEL PSICÓLOGO EN LA POST·PANDEMIA: Una mirada desde la Psicología de la Emergencia. Open
El presente trabajo enfatiza la la mirada transversal que aporta la Psicología de la Emergencia [PE], rama emergente de la disciplina que permite conocer y comprender las reacciones de las personas o grupos en situaciones de emergencias y/…
View article: Multicenter Validation of Metabolic Abnormalities Related to <scp>PSP</scp> According to the <scp>MDS‐PSP</scp> Criteria
Multicenter Validation of Metabolic Abnormalities Related to <span>PSP</span> According to the <span>MDS‐PSP</span> Criteria Open
It remains unclear whether the supportive imaging features described in the diagnostic criteria for progressive supranuclear palsy (PSP) are suitable for the full clinical spectrum. The aim of the current study was to define and cross‐vali…
View article: 18F-FDG-PET Imaging Patterns in Autoimmune Encephalitis: Impact of Image Analysis on the Results
18F-FDG-PET Imaging Patterns in Autoimmune Encephalitis: Impact of Image Analysis on the Results Open
Brain positron emission tomography imaging with 18Fluorine-fluorodeoxyglucose (FDG-PET) has demonstrated utility in suspected autoimmune encephalitis. Visual and/or assisted image reading is not well established to evaluate hypometabolism/…
View article: EANM practice guideline/SNMMI procedure standard for dopaminergic imaging in Parkinsonian syndromes 1.0
EANM practice guideline/SNMMI procedure standard for dopaminergic imaging in Parkinsonian syndromes 1.0 Open
View article: Proven validity and management impact of amyloid imaging in Alzheimer’s disease—repetita juvant
Proven validity and management impact of amyloid imaging in Alzheimer’s disease—repetita juvant Open
View article: Plasma Aβ42/40 ratio alone or combined with FDG-PET can accurately predict amyloid-PET positivity: a cross-sectional analysis from the AB255 Study
Plasma Aβ42/40 ratio alone or combined with FDG-PET can accurately predict amyloid-PET positivity: a cross-sectional analysis from the AB255 Study Open
View article: Correction: Hypofractionated radiation therapy and temozolomide in patients with glioblastoma and poor prognostic factors. A prospective, single-institution experience
Correction: Hypofractionated radiation therapy and temozolomide in patients with glioblastoma and poor prognostic factors. A prospective, single-institution experience Open
[This corrects the article DOI: 10.1371/journal.pone.0217881.].